Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jan 24,2018
Nonviral Gene Therapy Platform Delivers CRISPR/Cas9 to Tumors
Gene editing is one of the hottest topics in cancer research.  A platform for gene delivery and tumor therapy has been introduced that harnesses the power of the CRISPR/Cas9 gene-editing system. At the same time, the platform avoids some of the drawbacks of the CRISPR/Cas9 system. Specifically, the platform can cope with CRISPR/Cas9's sheer bulk,Read more
More
Nonviral Gene Therapy Platform Delivers CRISPR/Cas9 to Tumors
Jan 24,2018
Cancer Stem Cells "Hedge” Their Bets with Noncanonical Signaling
A collaborative team of scientists working as part of the OncoTrack project – an international consortium of scientists funded as part of the European Innovative Medicines Initiative – have recently discovered that cancer stem cells (CSCs) utilize a noncanonical signaling pathway, employing the Hedgehog protein and a positive regulator of WNT. The research team focusedRead more
More
Cancer Stem Cells "Hedge” Their Bets with Noncanonical Signaling
Jan 24,2018
DNA Sequencing Services
What is DNA Sequencing? – Determining the precise order of nucleotides in a piece of DNA. – DNA sequence is useful in studying fundamental biological processes and in applied fields such as diagnostic or forensic research. – DNA sequencing methods have been around for 40 years, and since the mid-1970s. DNA Sequencing Goal: Find theRead more
More
DNA Sequencing Services
Jan 23,2018
Scientists Develop Single Blood Test That Detects Eight Common Cancers
A research team headed by scientists at Johns Hopkins Kimmel Cancer Center has developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer. The test, called CancerSEEK, identifies eight circulating protein biomarkers and a panel of mutations in 16 cancer genes. When tested on bloodRead more
More
Scientists Develop Single Blood Test That Detects Eight Common Cancers
Jan 23,2018
New Nitric Oxide-Converting Enzymes Discovered
Even the smallest molecule can change the course of a cell's future, an apropos modification of J.R.R. Tolkien's writing from the "The Fellowship of the Ring” with respect to a recent discovery by investigators at Case Western Reserve University (CWRU). These researchers have uncovered previously unknown enzymes in the body that convert nitric oxide (NO)Read more
More
New Nitric Oxide-Converting Enzymes Discovered
Jan 22,2018
Novel Biomaterials Boost T-Cell Production
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, chemical-based approaches. These "living drugs” are poised to transform medicine, with a growing number of cellular therapies receiving FDA-approval.  Read more
More
Jan 22,2018
Learning Gene Passes between Neurons via Retrovirus-Like Mechanism
A neuron's genetic material can literally "go viral.” The genetic material, messenger RNA (mRNA) from the Arc gene, can be passed from neuron to neuron via extracellular vesicles and capsids, rather like retroviral RNA. This finding, which emerged from two recent studies, helps explain why the Arc protein shares features with proteins found in certainRead more
More
Jan 19,2018
Magnetically Applied MicroRNAs Could One Day Help Relieve Constipation
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging. Now, investigators from Thomas Jefferson University (TJU) have just released data of a new technique – called magnetofection – that incorporatesRead more
More
Jan 19,2018
Cancer Immunotherapy Channeled via Remote Control
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.   We're a long way from controlling our immune systems as easily as we might change the channels on our televisions, but a new remote-controlRead more
More
Jan 18,2018
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
Researchers have developed a biomaterial scaffold that mimics the actions of antigen-presenting cells (APCs) in stimulating T cell growth and survival. The scaffold allowed the researchers to significantly expand T cell numbers in a dish, compared with existing culture methods, and could bring T cell therapies, such as anti-cancer treatments, closer to clinical reality. LedRead more
More
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->